Achieve Life Sciences Inc.

NASDAQ:ACHV   3:21:03 PM EDT
7.01
+0.14 (+2.04%)
Earnings Announcements

Achieve Reports Financial Results For Third Quarter 2021 And Provides Update On Cytisinicline Development

Published: 11/09/2021 22:25 GMT
Achieve Life Sciences Inc. (ACHV) - Achieve Reports Financial Results for Third Quarter 2021 and Provides Update on Cytisinicline Development.
Achieve Life Sciences Inc - Qtrly Loss per Share $0.71.
Revenue is expected to be $0.05 Million
Adjusted EPS is expected to be -$0.69

Next Quarter Revenue Guidance is expected to be $0.05 Million
Next Quarter EPS Guidance is expected to be -$0.75

More details on our Analysts Page.